Clan Group Of Companies:

Edict Pharmaceuticals

  • Edict Pharmaceuticals Private Limited is a 100% Export Oriented Unit (EOU) engaged in “Product Development and Manufacturing” of Generic pharmaceutical formulations for United States of America (USA) and other Regulated markets.
  • Edict Pharmaceuticals has the benefit of technical guidance from renowned scientists from USA and qualified scientists working from Chennai in India.. Edict Pharmaceuticals offers the dual benefit of US standards at Indian Cost.
  • The state-of-the-art Research & Development (R&D) and Manufacturing facility of Edict Pharmaceuticals is built as per the requirements of USFDA.
  • The facility was approved by USFDA

Delvin Formulations Pvt. Ltd.

  • To Launch Patented international quality formulations in India.
  • To Deliver more value to Patients, Doctors, Traders & Business Associates.
  • Our marketing focus is to provide Innovative, Appropriate & Quality dosage forms which would benefit a large sect of population.
  • Supported by a strong R & D pipeline in India, We aim to meet customer requirements with at most Care.
  • We are constantly driven by our commitment of providing the same and Best Quality products to every one across the world.

Numen Health Care Pvt. Ltd.

  • Numen health care is a global trading company which will primarily trade pharmaceutical products across the globe.
  • Currently Numen entered in to an agreement with Sai Mirra Innopharm Pvt. Ltd to distribute their products to various countries including Malaysia, Singapore, Philippines, Vietnam, other South East Asian Countries, African Countries etc.
  • The product will be manufactured in India in Sai Mirra’s manufacturing facility and will be distributed to various customers through Numen Health care Pvt. Ltd.
  • The company has customers from more than twenty five countries currently and is planning to expand its wing across the globe.
  • The promoters are well versed with the business and are successful entrepreunurs already.
  • Numen will go to newer heights soon in the pharmaceutical trading
Scroll to Top